Bifidobacterium pseudocatenulatum CECT 7765 supplementation restores altered vascular function in an experimental model of obese mice

International Journal of Medical Sciences

Volumn 14, Issue 5, 2017, Pages 444-451

  Mauricio, María D ^a,b   Serna, Eva ^a   Fernández Murga, María Leonor ^c   Portero, Jesica ^a   Aldasoro, Martín ^a,b   Valles, Soraya L ^a,b   Sanz, Yolanda ^c   Vila, José M ^a,b  

^a UNIVERSITY OF VALENCIA   (Spain)

^b HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^c INSTITUTO DE AGROQUÍMICA Y TECNOLOGÍA DE ALIMENTOS CSIC   (Spain)

Author keywords

Bifidobacterium; Nitric oxide; Obesity; Vascular reactivit

Indexed keywords

ACETYLCHOLINE; INSULIN; LEPTIN; NITROPRUSSIDE SODIUM; NORADRENALIN; PROBIOTIC AGENT; ENDOTHELIAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE; NOS3 PROTEIN, MOUSE;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; AORTIC CONSTRICTION; ARTERY DILATATION; ARTICLE; BIFIDOBACTERIUM PSEUDOCATENULATUM; CONTROLLED STUDY; DOSE RESPONSE; ENOS GENE; EXPERIMENTAL OBESITY; GENE; GENE EXPRESSION; INSULIN BLOOD LEVEL; LIPID DIET; MALE; MOUSE; NONHUMAN; SUPPLEMENTATION; VASCULAR DISEASE; WEIGHT GAIN; ANIMAL; CHEMISTRY; DIET THERAPY; DIETARY SUPPLEMENT; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; MOUSE MUTANT; OBESITY; PATHOLOGY; VASCULAR REMODELING;

ANIMALS; BIFIDOBACTERIUM PSEUDOCATENULATUM; DIET, HIGH-FAT; DIETARY SUPPLEMENTS; GENE EXPRESSION REGULATION; HUMANS; MICE; MICE, OBESE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; NITROPRUSSIDE; OBESITY; PROBIOTICS; VASCULAR REMODELING;

EID: 85018726749     PISSN: 14491907     EISSN: None     Source Type: Journal    
DOI: 10.7150/ijms.18354     Document Type: Article

References (38)

1. Mauricio MD, Aldasoro M, Ortega J, Vila JM. Endothelial dysfunction in morbid obesity. Curr Pharm Des. 2013;19:5718–29.
2. Park YH, Kim JG, Shin YW, Kim SH, Whang KY. Effect of dietary inclusion of Lactobacillus acidophilus ATCC 43121 on cholesterol metabolism in rats. J Microbiol Biotechnol. 2007;17:655–62.
3. Sato M, Uzu K, Yoshida T, Hamad EM, Kawakami H, Matsuyama H, et al. Effects of milk fermented by Lactobacillus gasseri SBT2055 on adipocyte size in rats. Br J Nutr. 2008;99:1013–7.
4. Xiao JZ, Kondo S, Takahashi N, Miyaji K, Oshida K, Hiramatsu A, et al. Effects of milk products fermented by Bifidobacterium longum on blood lipids in rats and healthy adult male volunteers. J Dairy Sci. 2003 Jul;86(7):2452–61.
5. Cano PG, Santacruz A, Trejo FM, Sanz Y. Bifidobacterium CECT 7765 improves metabolic and immunological alterations associated with obesity in high-fat diet-fed mice. Obes Silver Spring Md. 2013;21:2310–21.
6. Moya-Pérez A, Romo-Vaquero M, Tomás-Barberán F, Sanz Y, García-Conesa M-T. Hepatic molecular responses to Bifidobacterium pseudocatenulatum CECT 7765 in a mouse model of diet-induced obesity. Nutr Metab Cardiovasc Dis NMCD. 2014;24:57–64.
7. Moya-Pérez A, Neef A, Sanz Y. Bifidobacterium pseudocatenulatum CECT 7765 Reduces Obesity-Associated Inflammation by Restoring the Lymphocyte-Macrophage Balance and Gut Microbiota Structure in High-Fat Diet-Fed Mice. PloS One. 2015;10(7):e0126976.
8. Franklin BA, Kahn JK. Delayed progression or regression of coronary atherosclerosis with intensive risk factor modification. Effects of diet, drugs, and exercise. Sports Med Auckl NZ. 1996;22:306–20.
9. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 1993;362:801–9.
10. Schiffrin EL. A critical review of the role of endothelial factors in the pathogenesis of hypertension. J Cardiovasc Pharmacol. 2001;38 Suppl 2:S3-6.
11. Félétou M, Vanhoutte PM. Endothelial dysfunction: a multifaceted disorder (The Wiggers Award Lecture). Am J Physiol Heart Circ Physiol. 2006;291:H985-1002.
12. Rashid SK, Idris-Khodja N, Khodja NI, Auger C, Alhosin M, Boehm N, et al. Probiotics (VSL#3) prevent endothelial dysfunction in rats with portal hypertension: role of the angiotensin system. PloS One. 2014;9(5):e97458.
13. Toral M, Gómez-Guzmán M, Jiménez R, Romero M, Sánchez M, Utrilla MP, et al. The probiotic Lactobacillus coryniformis CECT5711 reduces the vascular pro-oxidant and pro-inflammatory status in obese mice. Clin Sci Lond Engl 1979. 2014;127:33–45.
14. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods San Diego Calif. 2001;25:402–8.
15. Traupe T, Lang M, Goettsch W, Münter K, Morawietz H, Vetter W, et al. Obesity increases prostanoid-mediated vasoconstriction and vascular thromboxane receptor gene expression. J Hypertens. 2002;20:2239–45.
16. Nascimento TB, Baptista R de FF, Pereira PC, Campos DHS, Leopoldo AS, Leopoldo APL, et al. Vascular alterations in high-fat diet-obese rats: role of endothelial L-arginine/NO pathway. Arq Bras Cardiol. 2011;97:40–5.
17. Jerez S, Scacchi F, Sierra L, Karbiner S, de Bruno MP. Vascular hyporeactivity to angiotensin II and noradrenaline in a rabbit model of obesity. J Cardiovasc Pharmacol. 2012;59:49–57.
18. Hall J, Jones TH, Channer KS, Jones RD. Mechanisms of agonist-induced constriction in isolated human mesenteric arteries. Vascul Pharmacol. 2006;44:427–33.
19. Khan SF, et al. Dual effect of atorvastatin on endothelium; reduction in LDL and TXA2 levels but unaltered HCY levels in obese hyperlipidemic rats. Prof Med J. 2015;9:1496–1202.
20. Alexander RW, Griendling KK. Signal transduction in vascular smooth muscle. J Hypertens Suppl Off J Int Soc Hypertens. 1996;14:S51-54.
21. Sánchez A, Rojas P, Basfi-Fer K, Carrasco F, Inostroza J, Codoceo J, et al. Micronutrient Deficiencies in Morbidly Obese Women Prior to Bariatric Surgery. Obes Surg. 2016;26:361–8.
22. Gomes JMG, Costa JA, Alfenas RC. Could the beneficial effects of dietary calcium on obesity and diabetes control be mediated by changes in intestinal microbiota and integrity? Br J Nutr. 2015;114:1756–65.
23. Sobol CV, Korotkov SM, Belostotskaya GB, Nesterov VP. The influence of probiotics and probiotic product on respiration of mitochondria and intracellular calcium signal in cells of cardiovascular system. Biochem Mosc Suppl Ser Membr Cell Biol. 2013;7:294–301.
24. Bergillos-Meca T, Navarro-Alarcón M, Cabrera-Vique C, Artacho R, Olalla M, Giménez R, et al. The probiotic bacterial strain Lactobacillus fermentum D3 increases in vitro the bioavailability of Ca, P, and Zn in fermented goat milk. Biol Trace Elem Res. 2013;151:307–14.
25. Parvaneh K, Jamaluddin R, Karimi G, Erfani R. Effect of probiotics supplementation on bone mineral content and bone mass density. ScientificWorldJournal. 2014;2014:595962.
26. Gilman J, Cashman KD. The effect of probiotic bacteria on transepithelial calcium transport and calcium uptake in human intestinal-like Caco-2 cells. Curr Issues Intest Microbiol. 2006;7:1–5.
27. Ohlsson C, Engdahl C, Fåk F, Andersson A, Windahl SH, Farman HH, et al. Probiotics protect mice from ovariectomy-induced cortical bone loss. PloS One. 2014;9(3):e92368.
28. Segarra G, Lluch P, Mauricio MD, Vila JM, Medina P, Martinez-León JB, et al. Contractile hyporesponsiveness to norepinephrine of forearm veins in chronic renal failure. Am J Hypertens. 2006;19:818–22.
29. Angus JA, Cocks TM, Satoh K. The alpha adrenoceptors on endothelial cells. Fed Proc. 1986;45:2355–9.
30. Dora KA, Doyle MP, Duling BR. Elevation of intracellular calcium in smooth muscle causes endothelial cell generation of NO in arterioles. Proc Natl Acad Sci U S A. 1997;94:6529–34.
31. Martínez C, Vila JM, Aldasoro M, Medina P, Chuan P, Lluch S. The human deferential artery: endothelium-mediated contraction in response to adrenergic stimulation. Eur J Pharmacol. 1994;261:73–8.
32. Sivitz WI, Wayson SM, Bayless ML, Sinkey CA, Haynes WG. Obesity impairs vascular relaxation in human subjects: hyperglycemia exaggerates adrenergic vasoconstriction arterial dysfunction in obesity and diabetes. J Diabetes Complications. 2007;21:149–57.
33. Steinberg HO, Chaker H, Leaming R, Johnson A, Brechtel G, Baron AD. Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance. J Clin Invest. 1996;97:2601–10.
34. Perticone F, Ceravolo R, Candigliota M, Ventura G, Iacopino S, Sinopoli F, et al. Obesity and body fat distribution induce endothelial dysfunction by oxidative stress: protective effect of vitamin C. Diabetes. 2001;50:159–65.
35. Kobayasi R, Akamine EH, Davel AP, Rodrigues MAM, Carvalho CRO, Rossoni LV. Oxidative stress and inflammatory mediators contribute to endothelial dysfunction in high-fat diet-induced obesity in mice. J Hypertens. 2010;28:2111–9.
36. Montagnani M, Chen H, Barr VA, Quon MJ. Insulin-stimulated activation of eNOS is independent of Ca2+ but requires phosphorylation by Akt at Ser(1179). J Biol Chem. 2001;276:30392–8.
37. Cheng C-P, Tsai S-W, Chiu CP, Pan T-M, Tsai T-Y. The effect of probiotic-fermented soy milk on enhancing the NO-mediated vascular relaxation factors. J Sci Food Agric. 2013;93:1219–25.
38. Tripolt NJ, Leber B, Blattl D, Eder M, Wonisch W, Scharnagl H, et al. Short communication: Effect of supplementation with Lactobacillus casei Shirota on insulin sensitivity, β-cell function, and markers of endothelial function and inflammation in subjects with metabolic syndrome--a pilot study. J Dairy Sci. 2013;96:89–95.